Medication-assisted treatment (MAT) is widely accepted as the most effective form of treatment for...
parental substance use
After High School – Talking With Your Young Adult About Underage Drinking
This updated fact sheet is to inform parents how to effectively talk to their young adult about...
Connecting Communities to Substance Use Services: Practical Tools for First Responders
This guide provides practical, evidence-based information that first responder agencies, their...
2023-2026 SAMHSA Strategic Plan
The 2023–2026 SAMHSA Strategic Plan presents a new person-centered mission and vision highlighting...
Practice-Based Guidelines: Buprenorphine in the Age of Fentanyl
This guide provides clinical practice-based information on the use of buprenorphine in the...
What Do We Know About “Gaming Disorder”?
Video game playing is now one of the most popular hobbies across sex and age groups, but a small...
Taking Action to Break Language Barriers
The Addiction Policy Forum released prevention resources translated into 12 languages to help...
Key Takeaways from Rx Summit 2023
This summit is the largest, most influential annual event addressing the opioid and addiction...
Illicitly Manufactured Fentanyl–Involved Overdose Deaths with Detected Xylazine — United States, January 2019–June 2022
The Centers for Disease Control and Prevention (CDC) published a new report, Illicitly...
An Early Look at State Opioid Settlement Spending Decisions – NASHP
This issue brief provides an overview of published statewide opioid settlement spending plans and...
The ASAM Criteria 4th Edition Webinar Handout
The ASAM Criteria 4th Edition Webinar Handout
Addressing Substance Use and Social Needs of People of Color with Substance Use Disorders
This brief by the US Health and Human Services Office of Minority Health and the Office of the...